| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/07/1996 | EP0695170A1 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles |
| 02/07/1996 | EP0666921A4 Monocot having dicot wound inducible promoter. |
| 02/07/1996 | EP0486661B1 Method for detecting a nucleotide sequence by sandwich hybridization |
| 02/07/1996 | EP0438600B1 Enzymes which participate in c-terminal amidation, and production and use thereof |
| 02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 02/07/1996 | CN1116239A Method for improving expressing and renaturation of recomposited ox prorennin |
| 02/07/1996 | CN1116238A Method for cultiating tomato with function of anti virus of mosaic of cucumber by gene engineering |
| 02/06/1996 | US5489743 Transgenic animal models for thrombocytopenia |
| 02/06/1996 | US5489742 Rat genome containing hla-b27 or dr4 genes |
| 02/06/1996 | US5489529 Two nucleotide sequence covalently joined together can genetic translation of rna |
| 02/06/1996 | US5489528 Recombinant core-streptavidin |
| 02/06/1996 | US5489527 Translation of m-RNA |
| 02/06/1996 | US5489524 Chimeric protein that has a human Rho motif and deoxyribonuclease activity |
| 02/06/1996 | US5489523 Exonuclease-deficient thermostable Pyrococcus furiosus DNA polymerase I |
| 02/06/1996 | US5489520 Process of producing fertile transgenic zea mays plants and progeny comprising a gene encoding phosphinothricin acetyl transferase |
| 02/06/1996 | US5489519 Multidrug resistance protein |
| 02/06/1996 | US5489517 Gramnegative bacteria are caused to express a gene consisting of outer membrane protein lamb, ompf signal sequence joined to a dna sequence encoding insulin-like growth factor-1 and a transcription termination sequence, recovering mature one |
| 02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
| 02/06/1996 | US5489514 DNA coding for growth-inhibitory factor and use thereof |
| 02/06/1996 | US5489508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 02/06/1996 | US5489432 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 02/06/1996 | US5489430 Poultry mycoplasma antigen, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same |
| 02/06/1996 | CA2155451A1 Dna sequences encoding novel biosynthetic insulin precursors and process for preparation of insulin |
| 02/06/1996 | CA1338032C Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/01/1996 | WO1996002674A1 Genetic diagnosis of prostate cancer |
| 02/01/1996 | WO1996002669A1 Conjugates of metal complexes and oligonucleotides, which specifically bond to specific target structures, agents containing these conjugates, their use in nmr diagnosis as well as process for their production |
| 02/01/1996 | WO1996002661A1 Process for producing protein capable of molecular weight reduction caused by protease of host-cell origin |
| 02/01/1996 | WO1996002660A1 Positional control of selenium insertion in polypeptides for x-ray crystallography |
| 02/01/1996 | WO1996002658A1 A method for large scale plasmid purification |
| 02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
| 02/01/1996 | WO1996002654A1 Toxoplasma gondii p30 protein expression cassette |
| 02/01/1996 | WO1996002653A1 Thermophilic fungal expression system |
| 02/01/1996 | WO1996002652A2 β-KETOACYL ACP REDUCTASE GENES FROM BRASSICA NAPUS |
| 02/01/1996 | WO1996002651A1 Ligation wity hammerhead ribozymes |
| 02/01/1996 | WO1996002650A2 Dna, constructs, cells and plants derived therefrom |
| 02/01/1996 | WO1996002649A1 Modified plant viruses as vectors of heterologous peptides |
| 02/01/1996 | WO1996002648A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 02/01/1996 | WO1996002647A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | WO1996002646A2 Growth control for cells encapsulated within bioartificial organs |
| 02/01/1996 | WO1996002645A2 Htk ligand |
| 02/01/1996 | WO1996002644A1 Mlk receptor tyrosine kinases |
| 02/01/1996 | WO1996002643A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 02/01/1996 | WO1996002642A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 02/01/1996 | WO1996002641A2 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
| 02/01/1996 | WO1996002640A1 Alpha-lactalbumin gene constructs |
| 02/01/1996 | WO1996002639A1 Constitutively activating adrenergic receptors |
| 02/01/1996 | WO1996002638A1 Granular formulation containing microorganisms, a process for the preparation and the use thereof |
| 02/01/1996 | WO1996002636A1 Genes encoding and method of expressing a novel enzyme: phthalyl amidase |
| 02/01/1996 | WO1996002634A1 Active calpain expressed by baculovirus |
| 02/01/1996 | WO1996002630A1 Analytical and preparative methods for purifying phthalyl amidase from xanthobacter agilis |
| 02/01/1996 | WO1996002576A1 Reconstituted human antibody against human interleukin-8 |
| 02/01/1996 | WO1996002574A1 Process for modifying the stability of antibodies |
| 02/01/1996 | WO1996002567A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | WO1996002565A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | WO1996002561A1 Interaction trap systems for detecting protein interactions |
| 02/01/1996 | WO1996002560A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002557A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/01/1996 | WO1996002556A2 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002552A1 Lung cancer marker |
| 02/01/1996 | WO1996002274A1 Conjugates made of metal complexes and oligonucleotides |
| 02/01/1996 | WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | WO1996002265A1 The cellular basis of transplant arteriosclerosis |
| 02/01/1996 | WO1996002257A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | WO1996002256A1 CLEAVAGE OF 5α-REDUCTASE MRNA |
| 02/01/1996 | WO1996002143A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 02/01/1996 | WO1996002140A1 ISOLATED p27 PROTEIN AND METHODS FOR ITS PRODUCTION AND USE |
| 02/01/1996 | WO1995035382A3 NOVEL AMYLOLYTIC ENZYMES DERIVED FROM THE B. LICHENIFORMIS α-AMYLASE, HAVING IMPROVED CHARACTERISTICS |
| 02/01/1996 | WO1995034668A3 The cytoplasmic inhibition of gene expression |
| 02/01/1996 | WO1995034655A3 Surface protein of staphylococcus aureus |
| 02/01/1996 | WO1995023225A3 Method and reagent for inhibiting the expression of disease related genes |
| 02/01/1996 | WO1995013385A3 Thrombin mutants |
| 02/01/1996 | DE4426429A1 Verfahren zum Einführen von DNA in höhere eukaryotische Zellen A method for introducing DNA into higher eukaryotic cells |
| 02/01/1996 | CA2694296A1 Growth control for cells encapsulated within bioartificial organs |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195564A1 .beta.-ketoacyl acp reductase genes from brassica napus |
| 02/01/1996 | CA2195533A1 Interruption of binding of mdm2 and p53 protein and therapeutic application thereof |
| 02/01/1996 | CA2195531A1 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
| 02/01/1996 | CA2195474A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | CA2195450A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | CA2195403A1 Lung cancer marker |
| 02/01/1996 | CA2195397A1 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195238A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | CA2194955A1 Htk ligand |
| 02/01/1996 | CA2194907A1 Reshaped human antibody against human interleukin-8 |
| 02/01/1996 | CA2194873A1 Condii toxoplasma p30 expression cassette |
| 02/01/1996 | CA2194861A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | CA2194783A1 Genes encoding and method of expressing a novel enzyme: phthalyl amidase |
| 02/01/1996 | CA2194763A1 Recombinant enzymatically active calpain expressed in a baculovirus system |
| 02/01/1996 | CA2194558A1 Conjugates made of metal complexes and oligonucleotides |
| 02/01/1996 | CA2194398A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/01/1996 | CA2193513A1 Alpha-lactalbumin gene constructs |
| 02/01/1996 | CA2192681A1 Granular formulation containing microorganisms, a process for the preparation and the use thereof |
| 02/01/1996 | CA2192342A1 A method for large scale plasmid purification |
| 02/01/1996 | CA2190760A1 Dna, constructs, cells and plants derived therefrom |